Pipeline Biomedical Holdings

About Pipeline Biomedical Holdings

Pipeline Biomedical Holdings, Inc. operated as a medical device company with a strategic focus on identifying, developing, and commercializing novel orthopedic products and technologies.

Founded in 2007, the company established itself by developing and manufacturing orthopedic devices, implants, and related instruments. Its business model centered on advancing its own in-house concepts while also evaluating, capitalizing, and managing external businesses with compelling intellectual property. The firm actively sourced ideas and technologies through partnerships with universities, venture capital firms, medical institutions, and individual inventors. Its primary market segments included medical implants, operating room equipment, and surgical instruments.

A significant milestone in the company's history was its partnership with MAKO Surgical Corp., which began in 2010. Pipeline Biomedical became a crucial supplier for MAKO, developing advanced implant technologies specifically for MAKO's RIO® Robotic-Arm Interactive Orthopedic system. Key products developed under this collaboration included the proprietary MAKO-branded RESTORIS® PST Cup and Tapered Stem hip implant system, designed for use with the MAKOplasty® Total Hip Arthroplasty application.

The successful partnership culminated in the acquisition of substantially all of Pipeline Biomedical Holdings' assets by MAKO Surgical Corp. on October 8, 2013. The transaction was valued at approximately $116.8 million, consisting of a $2.5 million cash payment and nearly 4 million shares of MAKO stock. This event marked the conclusion of Pipeline Biomedical's journey as an independent entity, integrating its specialized implant technologies into MAKO's robotic surgery ecosystem just as MAKO itself was being acquired by Stryker.